180 followers
Important pre-clinical work showing the potential of inhibiting PI3Kd+PI3Ka in activated B-cell-like #DLBCL. Dr. Georgios Ponas @pongasg at @UMNCancer is moving the field toward more personalized targeted 🎯therapies in #lymphoma. | https://t.co/L7d3GYWnnG